Accanito Therapeutics
PrivateLast Round
Grant
Dec 2, 2021
Company Overview
Accanito Therapeutics operates in Healthcare & Life Sciences and is based in Mill Valley, California. Its latest recorded funding round was a Grant round in December 2021.
Accanito Therapeutics is an oncology company that develops mitochondria-targeted therapies to selectively eliminate cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accanito Therapeutics Comparables
Compare Accanito Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bantam Pharmaceutical | 83% | |
| SmartinBio Co., Ltd. | 82% | |
| MitoTax s.r.o. | 81% |
For institutional investors. Book with your work email.
Accanito Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Accanito Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| U.S. Army Medical Research and Development Command | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2021
Received funding from Gateway for Cancer Research, National Cancer Institute, and U.S. Army.
For institutional investors. Book with your work email.
Accanito Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Accanito Therapeutics's valuation, stock price, and market status.
Is Accanito Therapeutics a public or private company?
Accanito Therapeutics is a private company.
What is the current stock price of Accanito Therapeutics?
Accanito Therapeutics is a private company, so its shares have no public market price. Caplight tracks Accanito Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Accanito Therapeutics worth (valuation)?
Valuation information for Accanito Therapeutics is not publicly available.
Can I buy Accanito Therapeutics stock?
Accanito Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Accanito Therapeutics's last funding round?
Accanito Therapeutics's most recent funding round was Grant on December 2, 2021.
Who are the main investors in Accanito Therapeutics?
Key investors in Accanito Therapeutics include National Cancer Institute, U.S. Army Medical Research and Development Command.
Will Accanito Therapeutics IPO soon?
No public IPO plans have been announced for Accanito Therapeutics.
How can I track Accanito Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Accanito Therapeutics's shares on secondary markets.